ASTRO: Less intense chemoradiation may be possible for HPV-related oropharyngeal cancers
October 31, 2015|Oncology Practice
Author and Disclosure Information
AT THE ASTRO ANNUAL MEETING
And, as for his group’s further research plans, Dr. Chera noted in an interview that further follow-up would be required to determine if the regimen used was efficacious and safe. A second phase II trial with the same deintensified regimen in which surgery or biopsies were not mandated is about to close soon, and there is a third study that will look at using genetic information to determine if it is safe to deintensifty patients’ treatment.
Dr. Chera had no conflicts of interest to disclose.
